CTRI/2025/02/081354尚未招募2/3 期
A Randomized Controlled Clinical Study to evaluate add on effect of Shunthi Ghritha with Navayasa Loha in Panduroga vis-a-vis Iron Deficiency Anemia.
Dr Vajreshwari1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年3月20日最近更新:
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Reduction in symptoms of Panduroga assessed by subjective criteria
研究概览
简要总结
This study is a randomized, comparative clinical trail to evaluate the add on effect of Shunthi ghritha 12 grams twice daily along with Navayasa loha 500 mg twice daily in Group A with minimum of 15 patients, Navayasa loha 500 mg twice daily in Group B with minimum of 15 patients in the management of Panduroga vis-a-vis Iron deficiency anemia for a period of 30 days. The primary outcome is reduction in symptoms of Panduroga and the secondary outcome is improvement in subjects condition.
研究设计
- 研究类型
- Interventional
- 分配方式
- Coin toss, Lottery, toss of dice, shuffling cards etc
- 盲法
- None
入排标准
- 年龄范围
- 20.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Subjects of both gender between the age group of 20-60 years who fit into diagnostic criteria will be included.
- •Subjects presenting with pratyatma lakshana of Panduroga that include panduta, agnimandya, dourbalya, shrama, arohanaayasa, gatrashula, aruchi, bhrama, pindikodwestana, karnaksweda .etc.
- •Subjects with mild to moderate anemia with Hb concentration of 8-11.99% in females and 8-12.99% in males.
- •Subjects who are willing to provide informed consent will be included.
排除标准
- •Subjects having severe anemia with Hb less than 8gm% will be excluded from the study.
- •Subjects having any other systemic diseases and under medications which interfere with the disease process and the present clinical trial will be excluded.
- •Pregnancy, lactation and puerperal stage will be excluded.
- •Subjects suffering from bleeding disorders, infective, metabolic or endocrinal disorders and autoimmune diseases will be excluded.
- •Subjects known case of Sickle cell anemia, Thalassemia, Leukemia, Hemophilia, Sideroblastic anemia, etc.
- •will be excluded.
结局指标
主要结局
Reduction in symptoms of Panduroga assessed by subjective criteria
时间窗: 30th day
次要结局
- Improvement in subjects condition assessed by objective criteria(30th day)
研究者
Dr Vajreshwari
Sushrutha Ayurvedic Medical College and Hospital
研究点 (1)
Loading locations...
相似试验
尚未招募
2/3 期
A clinical trial to study application of medicated paste on eyelid for eyelids inflammationCTRI/2025/01/079624Dr chand babu Siddiqui42
尚未招募
2 期
EFFECT OF SHUNTHYADI CHURNA AND SHATAVARI TAILA MATRA BASTI ON HEAVY MENSUSCTRI/2024/11/076564Madan Mohan Malviya Govt. Ayurved College Udaipur30
招募中
2/3 期
A Study to compare efficacy of Go-Ghrita Aschyotana and Shadanga Guggulu in Shushkakshipaka (Computer Vision Syndrome)CTRI/2025/02/081243Madan Mohan Malviya Government Ayurved College Udaipur Rajasthan60
尚未招募
Phase 3 4
A study to see the effect of Shunthi Gairik Lepa in treatment of Anjananamika.CTRI/2025/04/084872No35
尚未招募
2/3 期
To study the effect of snuhi kshar pratisaran in treatment of kadar with special referance to cornCTRI/2025/05/086846Dr Sachin Anant Ratnaparkhi60